☆ 4.2 Letter

Bortezomib-Containing Multimodality Treatment for Antibody-Mediated Rejection with Anti-HLA and Anti-AT1R Antibodies after Kidney Transplantation

YONSEI MEDICAL JOURNAL (2017)

Get Full Text
Add to Collection

Journal

YONSEI MEDICAL JOURNAL
Volume 58, Issue 3, Pages 679-681

Publisher

YONSEI UNIV COLL MEDICINE
DOI: 10.3349/ymj.2017.58.3.679

Keywords

-

Categories

Medicine, General & Internal

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.